cnbc.com
Cramer Sells Honeywell, Eyes Home Depot Amid Market Rally
Jim Cramer's Charitable Trust sells Honeywell stock, capitalizing on market strength and addressing underperformance. Proceeds would have been reinvested in Home Depot, but trading restrictions apply.
English
United States
EconomyUs PoliticsInvestmentStocksMarketTrading
HoneywellJim Cramer's Charitable TrustCnbcHome DepotNbc News
Jim CramerDonald Trump
- What is the overall investment strategy reflected in this trade?
- The sale of Honeywell represents a strategic decision to profit from a market rally and adjust portfolio holdings based on individual stock performance and near-term economic predictions. The trust maintains a long-term outlook, focusing on securing gains and managing risks.
- Why did Jim Cramer's Charitable Trust sell its Honeywell shares?
- Jim Cramer's Charitable Trust sold 75 shares of Honeywell (HON) at approximately $216 per share, reducing its HON holdings to 325 shares and its weighting to 2% from 2.45%. This decision was driven by the stock's lagging performance and uncertain growth outlook despite positive management actions.
- What market conditions influenced the decision to sell Honeywell?
- The sale of Honeywell shares occurred during a market upswing following Donald Trump's projected presidential election win. Cramer's trust chose to capitalize on this strength by selling less-favored stocks to avoid subsidizing underperforming assets.
- What were the trust's plans for the proceeds from the Honeywell sale?
- The trust would have used the proceeds from the Honeywell sale to buy Home Depot (HD) shares if not for restrictions on trading stocks mentioned on CNBC within the past 72 hours. Rising interest rates due to anticipated inflationary pressures from potential policy changes have impacted Home Depot's outlook but not derailed the long-term investment thesis.
- What were the key factors contributing to Honeywell's recent underperformance?
- Honeywell's recent performance has been underwhelming, marked by missed revenue expectations and a lowered full-year sales outlook in the third quarter. While management initiatives show promise, execution issues and lagging organic sales growth have contributed to the stock's underperformance.